Charlie Verrier

Chemistry R&D Manager at Molsid
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
FR
Languages
  • French Native or bilingual proficiency
  • English Native or bilingual proficiency
  • Spanish Elementary proficiency
  • German Elementary proficiency
Skills

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Experience

  • Molsid
    • France
    • Biotechnology
    • 1 - 100 Employee
    • Chemistry R&D Manager
      • Oct 2019 - Present
  • INSA Lyon - Institut National des Sciences Appliquées de Lyon
    • France
    • Higher Education
    • 700 & Above Employee
    • post doctoral researcher
      • Jun 2017 - Sep 2019
  • ICIQ
    • Spain
    • Research Services
    • 100 - 200 Employee
    • Post doctoral researcher
      • Feb 2014 - May 2017
  • Lundbeck
    • Denmark
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • post doctoral researcher
      • Oct 2016 - Feb 2017

      I have been working within the drug discovery department under the supervision of Dr. Mauro Marigo. During this short stay, I studied photoredox-catalyzed late-stage C-H functionnalization of bioactive heterocyclic molecules developped in Lundbeck. I have been working within the drug discovery department under the supervision of Dr. Mauro Marigo. During this short stay, I studied photoredox-catalyzed late-stage C-H functionnalization of bioactive heterocyclic molecules developped in Lundbeck.

Education

  • Université Grenoble Alpes
    PhD, organic chemistry
    2008 - 2013
  • Université de Montpellier
    Bachelor's degree, Biomolecular Chemistry

Community

You need to have a working account to view this content. Click here to join now